HK1255390A1 - 用於生產***二酚和△-9-四氫***酚的方法 - Google Patents

用於生產***二酚和△-9-四氫***酚的方法

Info

Publication number
HK1255390A1
HK1255390A1 HK18114529.1A HK18114529A HK1255390A1 HK 1255390 A1 HK1255390 A1 HK 1255390A1 HK 18114529 A HK18114529 A HK 18114529A HK 1255390 A1 HK1255390 A1 HK 1255390A1
Authority
HK
Hong Kong
Prior art keywords
cannabidiol
tetrahydrocannabinol
delta
production
Prior art date
Application number
HK18114529.1A
Other languages
English (en)
Inventor
Dialer Lukas
Petrovic Denis
Weigl Ulrich
Original Assignee
Noramco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57730761&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1255390(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noramco Inc filed Critical Noramco Inc
Publication of HK1255390A1 publication Critical patent/HK1255390A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK18114529.1A 2015-07-10 2018-11-14 用於生產***二酚和△-9-四氫***酚的方法 HK1255390A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562191097P 2015-07-10 2015-07-10
US15/199,528 US10059683B2 (en) 2015-07-10 2016-06-30 Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
PCT/US2016/040635 WO2017011210A1 (en) 2015-07-10 2016-07-01 Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
HK1255390A1 true HK1255390A1 (zh) 2019-08-16

Family

ID=57730761

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114529.1A HK1255390A1 (zh) 2015-07-10 2018-11-14 用於生產***二酚和△-9-四氫***酚的方法

Country Status (21)

Country Link
US (4) US20170008869A1 (zh)
EP (2) EP3722276A1 (zh)
JP (2) JP6810842B2 (zh)
CN (1) CN108137526A (zh)
AU (2) AU2016294264B2 (zh)
BR (1) BR112018000497A2 (zh)
CA (1) CA2992043C (zh)
CL (2) CL2018000079A1 (zh)
CO (1) CO2018001290A2 (zh)
CR (1) CR20180094A (zh)
DK (1) DK3319952T3 (zh)
EC (1) ECSP18010065A (zh)
ES (1) ES2784881T3 (zh)
HK (1) HK1255390A1 (zh)
IL (1) IL256750A (zh)
MX (1) MX2018000354A (zh)
MY (1) MY182971A (zh)
NZ (1) NZ738925A (zh)
PH (1) PH12018500093A1 (zh)
PT (1) PT3319952T (zh)
WO (1) WO2017011210A1 (zh)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2531281A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
US20170008869A1 (en) * 2015-07-10 2017-01-12 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
JP2021513553A (ja) * 2018-02-13 2021-05-27 ビートルバング ファーマ リミテッド カンナビノイド誘導体並びにそのコンジュゲート及びその使用
CA3091776C (en) * 2018-02-20 2021-12-28 Supera Pharmaceuticals, Inc. Genetically modified cannabis sativa plants and modified cannabinoid compounds for treatment of substance addiction and other disorders
EP3814315A1 (en) 2018-06-28 2021-05-05 Symrise AG Synthesis of (+)-cannabinoids and their therapeutic effects
US10736869B2 (en) 2018-07-16 2020-08-11 ECS Health Sciences, Inc. Compositions and methods related to cannabinoids, terpenoids and essential oils
CN108863768A (zh) * 2018-08-03 2018-11-23 上海华堇生物技术有限责任公司 3,5-二甲氧基苯甲酰氯的制备方法
AU2019325479A1 (en) * 2018-08-20 2021-04-08 Bessor Pharma, Llc Novel cannabinoids and cannabinoid acids and their derivatives
WO2020051371A2 (en) * 2018-09-05 2020-03-12 Noramco, Inc. Cannabidiol compositions having modified cannabinoid profiles
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
EP3653596A1 (en) * 2018-11-14 2020-05-20 Indena S.p.A. Continuous flow synthesis of cannabidiol
DE102019104563A1 (de) * 2019-02-22 2020-08-27 Chiracon Gmbh Verfahren zur Herstellung von Cannabidiol
CN109970516A (zh) * 2019-03-20 2019-07-05 栾云鹏 一种工业化制备高纯度高收率的***酚类物质的合成方法
WO2020214574A1 (en) 2019-04-15 2020-10-22 Trustees Of Boston University One-step flow-mediated synthesis of cannabidiol (cbd) and derivatives
CN111943813B (zh) * 2019-05-17 2023-04-14 上海特化医药科技有限公司 ***二酚类化合物的制备方法
EP3959193A4 (en) * 2019-05-23 2022-07-13 Kare Chemical Technologies Inc. CATALYTIC CANNABINOID METHODS AND PRECURSORS
EP3976567A4 (en) * 2019-05-31 2023-10-04 Purisys LLC PROCESSES FOR PREPARING HALOGENATED DIHYDROXYBENZENE COMPOUNDS
US20220296482A1 (en) 2019-06-11 2022-09-22 Symrise Ag Synthesis and purification of cannabigerol and its application
WO2020252277A1 (en) * 2019-06-13 2020-12-17 Isomerz, Inc. Making delta 8 thc, delta 10 thc and/or cannabinol from cbd
US20220242810A1 (en) * 2019-06-14 2022-08-04 Purisys Llc Crystalline cannabigerol
US11542243B1 (en) 2019-09-26 2023-01-03 FusionFarms, LLC Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
CA3163788A1 (en) 2019-12-06 2021-06-10 JLABS Beauty LLC Topical compositions containing rose oil and cannabidiol and methods of making and using the same
CA3162971A1 (en) * 2019-12-27 2021-07-01 Charles K. Marlowe Preparation of cannabichromene and related cannabinoids
WO2021139739A1 (zh) * 2020-01-08 2021-07-15 成都百裕制药股份有限公司 ***二酚衍生物及其制备方法和在医药上的应用
EP4089081A4 (en) * 2020-01-08 2024-02-21 Chengdu Baiyu Pharmaceutical Co., Ltd. TETRAHYDROCANNABINOL DERIVATIVE AND ITS PREPARATION METHOD AND ITS MEDICAL USE
US20230059087A1 (en) * 2020-01-08 2023-02-23 Chengdu Baiyu Pharmaceutical Co., Ltd. Cannabidiol derivatives, preparation method thereof and use thereof
US20210230113A1 (en) * 2020-01-24 2021-07-29 Perkinelmer Health Sciences, Inc. Cannabinoid derivatives
US10981849B1 (en) * 2020-02-20 2021-04-20 Sci Pharmtech Inc. Method for preparing cannabinoids
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
AU2021235467A1 (en) 2020-03-12 2021-10-07 Council Of Scientific And Industrial Research Process for the synthesis of cannabidiol and intermediates thereof
CN116194431A (zh) 2020-03-31 2023-05-30 植物疗法有限公司 萜酚化合物及其用途
AU2021276680A1 (en) 2020-05-22 2023-01-19 Ilera Derm LLC Compositions for treating acne and dermatological conditions
CN112094257B (zh) * 2020-08-19 2023-08-22 公安部禁毒情报技术中心 一种△-9四氢***酚的制备方法
CN112811980B (zh) * 2020-12-01 2022-03-25 山东金城金奥医药科技有限公司 一种绿色光氧化连续制备***二酚中间体的方法
WO2022133332A2 (en) 2020-12-17 2022-06-23 Nalu Bio, Inc. Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use
US11242330B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Organic catalyst and method for preparation of aromatic tricyclic pyrans
US11242328B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans
US20220306598A1 (en) * 2021-03-25 2022-09-29 Precision Extraction Corporation Method for highly selective conversion of cbd to delta-8 thc
US11352337B1 (en) * 2021-06-02 2022-06-07 Acid Neutral Alkaline Laboratory Zeolite catalyst and method for preparation of aromatic tricyclic pyrans
CN113603568A (zh) * 2021-07-19 2021-11-05 厦门朝阳生物工程有限公司 一种***二酚的制备方法
WO2023086447A2 (en) * 2021-11-12 2023-05-19 Pureform Global, Inc. A method for the synthesis of cannabinol
WO2024028516A1 (en) 2022-08-05 2024-02-08 Salud & Semillas, S.L. CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl3 * 6H2O AS CATALYST

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473075A (de) 1966-11-04 1969-05-31 Theodor Dr Petrzilka Verfahren zur Herstellung von in 2-Stellung substituierten Resorcinderivaten
DE4100441A1 (de) 1991-01-09 1992-07-16 Mack Chem Pharm Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol
US6563009B1 (en) 1999-07-12 2003-05-13 Virginia Commonwealth University Vasodilator cannabinoid analogs
WO2003063847A1 (en) * 2002-02-01 2003-08-07 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
GB2393182B (en) * 2002-09-23 2007-03-14 Gw Pharma Ltd Method of preparing cannabidiol from plant material
JP2007501279A (ja) * 2003-05-20 2007-01-25 ユニバーシティ・オブ・テネシー・リサーチ・ファウンデイション カンナビノイド誘導体、その製造方法、および使用
US7323576B2 (en) 2004-10-01 2008-01-29 Alphora Research Inc. Synthetic route to dronabinol
TWI436991B (zh) * 2004-11-22 2014-05-11 Euro Celtique Sa 用於純化反-（-）-△９-四氫***酚與反-（＋）-△９-四氫***酚之方法
DE102005028937B4 (de) * 2005-06-22 2009-07-23 Bionorica Ag Verfahren zur Herstellung von Dronabinol
EP1928853A4 (en) 2005-09-29 2011-02-16 Amr Technology Inc PROCESS FOR THE PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL
CA2751741C (en) * 2008-02-06 2018-07-10 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
EP3274321B8 (en) * 2015-03-23 2019-10-23 Echo Pharmaceuticals B.V. Cannabidiol isolate from industrial-hemp and use thereof in pharmaceutical and/or cosmetic preparations
AU2016267585C1 (en) * 2015-05-28 2023-02-16 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
US20170008869A1 (en) * 2015-07-10 2017-01-12 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Also Published As

Publication number Publication date
CA2992043C (en) 2020-04-14
ES2784881T3 (es) 2020-10-01
US10059683B2 (en) 2018-08-28
US20210061781A1 (en) 2021-03-04
WO2017011210A1 (en) 2017-01-19
EP3319952B8 (en) 2020-03-11
NZ738925A (en) 2019-05-31
PH12018500093A1 (en) 2018-07-09
JP6810842B2 (ja) 2021-01-13
CN108137526A (zh) 2018-06-08
CR20180094A (es) 2018-06-14
EP3319952B1 (en) 2020-02-05
JP2018522944A (ja) 2018-08-16
JP2020037596A (ja) 2020-03-12
PT3319952T (pt) 2020-04-22
EP3722276A1 (en) 2020-10-14
CL2019003154A1 (es) 2020-03-06
IL256750A (en) 2018-03-29
CA2992043A1 (en) 2017-01-19
US20170008869A1 (en) 2017-01-12
EP3319952A1 (en) 2018-05-16
DK3319952T3 (da) 2020-03-23
ECSP18010065A (es) 2018-05-31
US20170008868A1 (en) 2017-01-12
AU2016294264A1 (en) 2018-02-01
US20180319763A1 (en) 2018-11-08
CO2018001290A2 (es) 2018-04-19
AU2019229416A1 (en) 2019-10-03
BR112018000497A2 (pt) 2018-09-11
US10844035B2 (en) 2020-11-24
MX2018000354A (es) 2018-08-15
CL2018000079A1 (es) 2018-08-24
MY182971A (en) 2021-02-05
AU2016294264B2 (en) 2019-06-13

Similar Documents

Publication Publication Date Title
HK1255390A1 (zh) 用於生產***二酚和△-9-四氫***酚的方法
IL258324B (en) Methods to create various cannabis product compounds
IL250757A0 (en) Device and methods for the simultaneous production of cannabinoid compounds
EP3291806A4 (en) Process to extract and purify delta-9-tetrahydrocannabinol
EP3212189A4 (en) Substituted chromanes and method of use
GB201510950D0 (en) In vitro Production of Cholangiocytes
ZA201704197B (en) Method for the production of praziquantel and precursors thereof
EP3180297A4 (en) Process for the manufacture of furural and furfural derivatives
PL3170912T3 (pl) Produkt stalowy oraz sposób jego wytwarzania
ZA201801917B (en) Process for the extraction of silica
HK1209187A1 (zh) 用於生產至少個分析裝置的工藝和生產裝置
PL3271325T3 (pl) Sposób wytwarzania (S)-metolachloru
IL257814A (en) Method for making praziquantal
PT3374074T (pt) Aparelho e processo para a produção de formaldeído
GB2531092B (en) Production of airframe components
EP3207020A4 (en) Method of making vitamin k1
PL3098072T3 (pl) Sposób wytwarzania laminatów
SG11201610277SA (en) Process for producing benzene and lpg2
GB2544164B (en) Process for modifying and/or increasing vitamin D content of mushrooms
GB201520078D0 (en) Apparatus and process for the production of formaldehyde
PL3224228T3 (pl) Sposób wytwarzania alkoholu i/lub ketonu z wodoronadtlenków
GB201415750D0 (en) Process for modifying and/or increasing vitamin D content of mushrooms
GB201509277D0 (en) Production of 3-alkylphenols and uses thereof
PT3271325T (pt) Processo de produção de (s)-metolacloro
HUP1500438A2 (en) Structure and method for the production of high temperatrure resistant lubricant